尼美舒利宽治疗时间窗对大鼠局灶性脑缺血的保护作用
Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat
摘要:
多项研究结果表明,环氧合酶-2(COX-2)参与缺血性脑损伤。本研究的目的是评价选择性COX-2抑制剂尼美舒利对大鼠短暂性局灶性脑缺血模型中脑梗死和神经功能缺损的神经保护作用。三个剂量的尼美舒利(3、6和12 mg/kg; i. p.)或赋形剂,并在缺血后6、12、24、36和48小时给予额外剂量。在另一组实验中,研究了尼美舒利在缺血后首次给药延迟3-24小时的情况下的作用。缺血后3天测定总的、皮质和皮质下梗死体积和功能结果(通过神经功能缺损评分和旋转棒性能评估)。同时观察尼美舒利对损伤脑组织前列腺素E2(PGE 2)水平的影响。与溶媒相比,尼美舒利剂量依赖性地减少梗死体积,改善功能恢复。有趣的是,当治疗延迟至缺血后24小时时,也观察到尼美舒利赋予的神经保护作用(梗死面积和神经功能缺损的减少以及旋转杆性能的改善)。此外,在延迟治疗模式中给予尼美舒利完全消除了缺血后脑中PGE(2)的积累,这表明COX-2抑制是一种有希望的脑缺血治疗策略,以靶向晚期发生的炎症事件,这些炎症事件放大了初始损伤。
英文摘要:
Results from several studies indicate that cyclooxygenase-2 (COX-2) is involved in ischemic brain injury. The purpose of this study was to evaluate the neuroprotective effects of the selective COX-2 inhibitor nimesulide on cerebral infarction and neurological deficits in a standardized model of transient focal cerebral ischemia in rats. Three doses of nimesulide (3, 6 and 12 mg/kg; i.p.) or vehicle were administered immediately after stroke and additional doses were given at 6, 12, 24, 36 and 48 h after ischemia. In other set of experiments, the effect of nimesulide was studied in a situation in which its first administration was delayed for 3-24 h after ischemia. Total, cortical and subcortical infarct volumes and functional outcome (assessed by neurological deficit score and rotarod performance) were determined 3 days after ischemia. The effect of nimesulide on prostaglandin E(2) (PGE(2)) levels in the injured brain was also investigated. Nimesulide dose-dependently reduced infarct volume and improved functional recovery when compared to vehicle. Of interest is the finding that neuroprotection conferred by nimesulide (reduction of infarct size and neurological deficits and improvement of rotarod performance) was also observed when treatment was delayed until 24 h after ischemia. Further, administration of nimesulide in a delayed treatment paradigm completely abolished PGE(2) accumulation in the postischemic brain, suggesting that COX-2 inhibition is a promising therapeutic strategy for cerebral ischemia to target the late-occurring inflammatory events which amplify initial damage.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。